The results demonstrated that the activity of lung histone RhoA was significantly enhanced in the BLM group of a bleomycin-induced lung fibrosis model, and the intervention of GL-V9 was found to effectively inhibit the enhancement of RhoA activity (Fig. 4D). This evidence concerns the gene RHOA and pulmonary fibrosis.